There was a significant increase in low-density lipoprotein cholesterol at week 12.

Fasting serum lipoprotein number and size was determined by nuclear magnetic resonance.

Background: Renal insufficiency is characterized by lipoprotein abnormalities including elevated triglyceride levels.

Background: Statins are widely prescribed to lower plasma low-density lipoprotein cholesterol levels.

The difference in atherosclerosis was not caused by altered serum lipoprotein levels.

These lipoprotein concentrations reverted to baseline values 24 weeks after drug discontinuation.

Very low-density lipoprotein apoB fractional secretion rate and pool size were unaffected.

Her low-density lipoprotein cholesterol and high-sensitivity C-reactive protein levels were not elevated.

We found that altered plasma lipoprotein metabolism can profoundly influence these events.

Acetylated low density lipoprotein significantly reduced the SP-A-stimulated uptake of the bacteria.

The structural basis of CD36-lipoprotein ligand recognition is an area of intense interest.

Conclusions: LHM represent an interesting translatable model of human hepatic and lipoprotein metabolism.

Purpose of review: To determine the potential clinical utility of high-density lipoprotein-mimetic peptides.

Nuclear Magnetic Resonance spectroscopy was used for the measurement of lipoprotein particle size.

These new clinical and biological insights reinforce the multifunctional role of lipoprotein lipase.

The parents of the patient were normolipemic but showed reduced lipoprotein lipase activity.